| Title : Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease - Alhainen_1991_Neurosci.Lett_127_113 |
| Author(s) : Alhainen K , Partanen J , Reinikainen K , Laulumaa V , Soininen H , Airaksinen M , Riekkinen P |
| Ref : Neuroscience Letters , 127 :113 , 1991 |
|
Abstract :
We report the results of our study suggesting that a single dose pharmaco-EEG may predict treatment response to tetrahydroaminoacridine (THA) in Alzheimer's disease (AD). 14 AD patients and 7 age-matched neurologically healthy controls were selected for the study. AD patients had 7 weeks' THA treatment. 6 patients were regarded as responders and 8 patients as nonresponders, respectively. AD patients as well as controls had a baseline EEG recording and next day another recording 90 minutes after a peroral single dose of 50 mg THA. The relative change from the baseline in the alpha-theta ratio was the most sensitive discriminator of responders and nonresponders (P = 0.004, ANOVA). |
| PubMedSearch : Alhainen_1991_Neurosci.Lett_127_113 |
| PubMedID: 1881606 |
Alhainen K, Partanen J, Reinikainen K, Laulumaa V, Soininen H, Airaksinen M, Riekkinen P (1991)
Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease
Neuroscience Letters
127 :113
Alhainen K, Partanen J, Reinikainen K, Laulumaa V, Soininen H, Airaksinen M, Riekkinen P (1991)
Neuroscience Letters
127 :113